Back
Pfizer, Inc. (PFE)
PharmaceuticalsPFE · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$28.57
+2.09%Weekly undervalued picks (like PFE)
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$1.36
ROE
8.3%
Gross margin
74.8%
Debt/Equity
0.72x
Revenue growth
5.4%
Pfizer, Inc. — company intelligence
Earnings surprises
Q2 2026$0.77 vs $0.69 est+11.4%
Q1 2026$0.75 vs $0.72 est+3.5%
Q4 2025$0.66 vs $0.58 est+14.3%
Q3 2025$0.87 vs $0.64 est+36.0%
Analyst consensus · 36 analysts
14 Buy20 Hold2 Sell
Updated Aug 16, 2026
Insider activity · 90 days
9 buys2 sellsnet +109,788 shares
BOURLA ALBERTBuy 38,000 · Aug 12, 2026
BLAYLOCK RONALD EBuy 39,231 · Aug 5, 2026
Buckley Mortimer JBuy 37,632 · Aug 5, 2026
Recent SEC filings
4 — Insider transaction reportAug 17, 2026
4 — Insider transaction reportAug 12, 2026
4 — Insider transaction reportAug 6, 2026
Latest news
10 Health Care Stocks Whale Activity In Today’s Session — Benzinga · 1d ago
Prelude Therapeutics: A Prognosis After Year-Long Rally — SeekingAlpha · 3d ago
Prediction: This Is Where Pfizer Stock Will Be in 2030 — Yahoo · 3d ago
This 'Dynamo' Biotech Puts AI-Fueled Breakout In Motion — Yahoo · 4d ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks (like PFE)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.